PNC Financial Services Group
NEOS

PNC Financial Services Group’s Neos Therapeutics, Inc NEOS Stock Holding History

PNC Financial Services Group’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-94
Closed – – 4214
2019
Q1 		$0 Hold
94
– – ﹤0.01% 4190
2018
Q4 		$0 Hold
94
– – ﹤0.01% 4252
2018
Q3 		$0 Hold
94
– – ﹤0.01% 4300
2018
Q2 		$0 Hold
94
– – ﹤0.01% 4331
2018
Q1 		$0 Hold
94
– – ﹤0.01% 4327
2017
Q4 		$0 Buy
+94
New +$902 ﹤0.01% 4296

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PNC Financial Services Group's NEOS Position: Q2 2019 in Review

PNC Financial Services Group sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 94 shares.

PNC Financial Services Group first reported a position in NEOS in Q4 2017 and held it in 6 quarters. The position peaked at $0 in Q1 2019. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • PNC Financial Services Group reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 94 Neos Therapeutics, Inc shares in Q2 2019.
  • PNC Financial Services Group first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 6 quarters.
  • PNC Financial Services Group's Neos Therapeutics, Inc position peaked at $0 in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on PNC Financial Services Group's 13F filing for Q2 2019, filed 9 Aug 2019.